{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:45:26Z","timestamp":1786149926789,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ygyno.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:58:46Z","timestamp":1781456326000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiovascular outcomes in individuals with ovarian cancer: A retrospective cohort study"],"prefix":"10.1016","volume":"211","author":[{"given":"Abdelrahman","family":"AlAshqar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary P.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ygyno.2026.06.008_bb0005","article-title":"Correction to: heart disease and stroke Statistics-2023 update: a report from the American Heart Association","volume":"147","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ygyno.2026.06.008_bb0010","author":"Cancer Statistics Center"},{"issue":"10203","key":"10.1016\/j.ygyno.2026.06.008_bb0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ygyno.2026.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset Cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.008_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2020.11.023","article-title":"The influence of individual and neighborhood-level characteristics on rural-urban disparities in cardiovascular disease mortality among U.S. women diagnosed with breast and gynecologic cancers","volume":"161","author":"Appiah","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.008_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2022.03.025","article-title":"Cardiovascular conditions and obesity among gynecologic cancer survivors: results from the 2020 behavioral risk factor surveillance system survey","volume":"165","author":"Coughlin","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.008_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2022.05.004","article-title":"The intersection of gynecologic cancer, obesity, and cardiovascular disease","volume":"165","author":"Felix","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2017.11.019","article-title":"The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study","volume":"148","author":"Kitson","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"25","key":"10.1016\/j.ygyno.2026.06.008_bb0045","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","article-title":"Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level","volume":"65","author":"Barac","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.008_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2021.05.021","article-title":"Cardiovascular medications and survival in people with ovarian cancer: a population-based cohort study from British Columbia, Canada","volume":"162","author":"Hanley","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.06.008_bb0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canep.2017.10.009","article-title":"Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women\u2019s Health Initiative","volume":"51","author":"Felix","year":"2017","journal-title":"Cancer Epidemiol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.06.008_bb0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCRESAHA.118.313779","article-title":"High-risk human papillomavirus infection and the risk of cardiovascular disease in Korean women","volume":"124","author":"Joo","year":"2019","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.008_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaccao.2023.02.002","article-title":"Cancer treatment-related cardiovascular toxicity in gynecologic malignancies: JACC: CardioOncology state-of-the-art review","volume":"5","author":"Parashar","year":"2023","journal-title":"JACC CardioOncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ygyno.2020.04.700","article-title":"Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES)","volume":"158","author":"Staples","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2026.06.008_bb0075","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1158\/1055-9965.EPI-13-0625","article-title":"Impact of cardiovascular comorbidity on ovarian cancer mortality","volume":"22","author":"Shinn","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.ygyno.2026.06.008_bb0080","first-page":"469","article-title":"History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium","volume":"28","author":"Minlikeeva","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ygyno.2026.06.008_bb0085","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3390\/curroncol28050313","article-title":"Survival in advanced epithelial ovarian cancer associated with cardiovascular comorbidities and type 2 diabetes mellitus","volume":"28","author":"Slavchev","year":"2021","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13048-024-01413-4","article-title":"Cardiovascular mortality risk in patients with ovarian cancer: a population-based study","volume":"17","author":"Hu","year":"2024","journal-title":"J. Ovarian Res."},{"issue":"8","key":"10.1016\/j.ygyno.2026.06.008_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59081476","article-title":"Cardiovascular mortality in ovarian cancer patients: an analysis of patient characteristics using the SEER database","volume":"59","author":"Al-Badawi","year":"2023","journal-title":"Medicina"},{"issue":"3 Pt 2","key":"10.1016\/j.ygyno.2026.06.008_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/gme.0b013e318038d333","article-title":"Surgical menopause and cardiovascular risks","volume":"14","author":"Lobo","year":"2007","journal-title":"Menopause"},{"issue":"24","key":"10.1016\/j.ygyno.2026.06.008_bb0105","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.06.008_bb0110","series-title":"Optum Labs and Optum Labs Data Warehouse (OLDW) Descriptions and Citation","author":"Optum Labs","year":"2023"},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.ygyno.2026.06.008_bb0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jamia\/ocw181","article-title":"Development and validation of a structured query language implementation of the Elixhauser comorbidity index","volume":"24","author":"Epstein","year":"2017","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"12","key":"10.1016\/j.ygyno.2026.06.008_bb0130","doi-asserted-by":"crossref","DOI":"10.4155\/cli.15.54","article-title":"A new SAS macro for flexible parametric survival modelling: applications to clinical trials and surveillance data","volume":"5","author":"Dewar","year":"2015","journal-title":"Clin. Invest."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/oby.23289","article-title":"Body composition and cardiometabolic health across the menopause transition","volume":"30","author":"Marlatt","year":"2022","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident cardiovascular disease among adults with cancer: a population-based cohort study","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC CardioOncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0145","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12885-020-07217-1","article-title":"Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling","volume":"20","author":"Maayah","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.008_bb0150","first-page":"281","article-title":"Left ventricular strain in chemotherapy-naive and radiotherapy-naive patients with cancer","volume":"34","author":"Tadic","year":"2018","journal-title":"Can. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.06.008_bb0155","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0959-8049(99)00131-8","article-title":"Paracrine regulation of ovarian cancer by endothelin","volume":"35","author":"Moraitis","year":"1999","journal-title":"Eur. J. Cancer"},{"issue":"22","key":"10.1016\/j.ygyno.2026.06.008_bb0160","first-page":"8340","article-title":"Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells","volume":"61","author":"Rosano","year":"2001","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.008_bb0165","first-page":"177","article-title":"Secretion of vascular endothelial growth factor in ovarian cancer","volume":"20","author":"Santin","year":"1999","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.06.008_bb0170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCRESAHA.108.178459","article-title":"Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy","volume":"103","author":"Karpanen","year":"2008","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.ygyno.2026.06.008_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002533","article-title":"Cancer and its association with the development of coronary artery calcification: an assessment from the multi-ethnic study of atherosclerosis","volume":"4","author":"Whitlock","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12997\/jla.2025.14.1.30","article-title":"Atherosclerotic cardiovascular disease in Cancer survivors: current evidence, risk prediction, prevention, and management","volume":"14","author":"Choi","year":"2025","journal-title":"J. Lipid Atheroscler."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.008_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","article-title":"Inflammation and ovarian cancer","volume":"58","author":"Maccio","year":"2012","journal-title":"Cytokine"},{"issue":"21","key":"10.1016\/j.ygyno.2026.06.008_bb0190","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.jacc.2020.03.067","article-title":"Mechanistic biomarkers informative of both Cancer and cardiovascular disease: JACC state-of-the-art review","volume":"75","author":"Narayan","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ygyno.2026.06.008_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2025.02.007","article-title":"Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity","volume":"111","author":"Zhang","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ygyno.2026.06.008_bb0200","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1009044","article-title":"Tumor-infiltrating clonal hematopoiesis and pan-cancer prognosis in patients with solid tumors","author":"Yun","year":"2026","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.ygyno.2026.06.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70444","article-title":"Clonal hematopoiesis in patients with cancer and cancer survivors: from clonal burden to cardiovascular diseases","volume":"132","author":"Nenninger","year":"2026","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2026.06.008_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/phar.70149","article-title":"Thrombosis across female-specific malignancies: from chemotherapy-driven risk to prophylaxis and drug interactions","volume":"46","author":"Aghakouchakzadeh","year":"2026","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ygyno.2026.06.008_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8388258","article-title":"Insights into the role of oxidative stress in ovarian cancer","volume":"2021","author":"Ding","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ygyno.2026.06.008_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ygyno.2026.06.008_bb0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncomms1601","article-title":"BRCA1 is an essential regulator of heart function and survival following myocardial infarction","volume":"2","author":"Shukla","year":"2011","journal-title":"Nat. Commun."},{"issue":"16_suppl","key":"10.1016\/j.ygyno.2026.06.008_bb0230","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2023.41.16_suppl.567","article-title":"Association of anthracyclines induced cardiotoxicity (AIC) in patients with early breast cancer (eBC) with germline BRCA1\/2 (gBRCA1\/2) mutation: BRCAN study","volume":"41","author":"Domingo","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.ygyno.2026.06.008_bb0235","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.008_bb0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13048-025-01636-z","article-title":"Ovarian cancer and the heart: pathophysiology, chemotherapy-induced cardiotoxicity, and new therapeutic strategies","volume":"18","author":"Nair","year":"2025","journal-title":"J. Ovarian Res."},{"issue":"14","key":"10.1016\/j.ygyno.2026.06.008_bb0245","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: a review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"issue":"65","key":"10.1016\/j.ygyno.2026.06.008_bb0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jncimonographs\/lgae022","article-title":"The SEER program\u2019s evolution: supporting clinically meaningful population-level research","volume":"2024","author":"Penberthy","year":"2024","journal-title":"J. Natl. Cancer Inst. Monogr."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826020287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826020287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:35:12Z","timestamp":1786149312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826020287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0090825826020287"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.06.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular outcomes in individuals with ovarian cancer: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}